首页> 外文OA文献 >Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder
【2h】

Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder

机译:长期服用盐酸奥昔布宁(KL007)对神经源性膀胱和不稳定膀胱的治疗作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The efficacy and safety of long-term administration of oxybutynin hydrochloride in patients with neurogenic bladder and unstable bladder, who complained of urinary frequency, urgency and incontinence, and whose bladder was proved to be uninhibited, reflex, and/or low compliant, were studied at the multi-center hospitals, and the following results were obtained. This study comprised 149 cases but 8 of them were excluded because of the incomplete protocol. Thus, 141 cases (104 neurogenic bladder patients, 33 unstable bladder patients and 4 others) were investigated. The daily dosage of Oxybutynin hydrochloride ranged from 1 to 18 mg, and averaged at 6.6 mg. Since a small daily dosage of 3 mg was administered in 32 cases to examine the minimum effective dosage of the drug, the low average dosage possibly resulted. The clinical optimal dosage seemed to be more than 6.6 mg. The average period of administration in all cases was 161.7 days (1-336 days), and the drug was discontinued in 46 cases (33.6%) on average 62.1 days (1-141 days). The rate of global improvement by this drug estimated at the time of completion was found to be 65.6% with excellent and good and 87.8% with excellent, good and fair. The efficacy of this drug was stable and not decreased during the long-term test period. As to the objective findings studied before, during and after the drug administration, cystometric bladder capacity was significantly increased both first desire to void and the total capacity. Voided volume and residual urine were also increased, but there was no change in the rate of residual urine. Side effects were observed in 37 (26.2%) of 141 cases, and mainly gastrointestinal signs such as dry mouth and constipation. Urological signs such as dysuria and urinary retention were experienced in 8 cases. Regarding the findings of laboratory tests, there were no abnormality except for small changes of some items in normal range. Six children who were younger than 15 years old were subjected to this study. The results of evaluation were similar to those obtained on adults and no side effects were observed. From these findings, oxybutynin hydrochloride is considered an effective and useful drug in patients suffering from neurogenic bladder and unstable bladder with over active bladder condition.
机译:研究了长期服用盐酸奥昔布宁对神经原性膀胱和不稳定膀胱患者的疗效和安全性,这些患者抱怨尿频,尿急和尿失禁,并且膀胱被抑制,反射和/或顺应性低,在多中心医院中,获得了以下结果。这项研究包括149例,但由于协议不完整而将其中8例排除在外。因此,调查了141例患者(104例神经源性膀胱患者,33例不稳定膀胱患者和4例)。盐酸奥昔布宁的日剂量范围为1至18 mg,平均为6.6 mg。由于在32例患者中每天3 mg的小剂量用于检查该药物的最小有效剂量,因此可能会导致平均剂量偏低。临床最佳剂量似乎超过6.6 mg。在所有情况下,平均给药时间为161.7天(1-336天),在46例(33.6%)中停药的平均时间为62.1天(1-141天)。发现该药物在完成时的总体改善率为良好和良好为65.6%,而优异,良好和一般为87.8%。在长期测试期间,该药的疗效稳定且未降低。至于在给药之前,期间和之后研究的客观发现,膀胱测压膀胱容量显着增加了首次排尿的欲望和总容量。空隙体积和残留尿液也增加了,但是残留尿液的速率没有变化。 141例患者中有37例(26.2%)出现了副作用,主要是胃肠道症状,如口干和便秘。 8例出现尿痛,排尿困难和尿retention留等症状。关于实验室检查的结果,除正常范围内的某些项目有微小变化外,没有其他异常。六个小于15岁的儿童接受了这项研究。评估结果与成年人获得的相似,并且未观察到副作用。根据这些发现,盐酸奥昔布宁被认为是患有神经源性膀胱和膀胱过度活动状态的不稳定膀胱患者的一种有效和有用的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号